FDA — authorised 19 April 1983
- Application: NDA018553
- Marketing authorisation holder: ANI PHARMS
- Status: supplemented
FDA authorised Inderal on 19 April 1983
Yes. FDA authorised it on 19 April 1983; FDA authorised it on 12 March 2003; FDA has authorised it.
ANI PHARMS holds the US marketing authorisation.